Smartlab Europe

USP opens new testing facility in India

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Lilly, Insilico Sign $2.75B AI Drug Discovery Collaboration

Eli Lilly has expanded its engagement with Insilico Medicine,...

Daiichi Sankyo Enter AI Oncology Collaboration with Tempus

Daiichi Sankyo has formalised a strategic agreement with Tempus...

FDA Seeks Input on National Priority Voucher Pilot Program

The U.S. Food and Drug Administration has initiated a...
- Advertisement -

US Pharmacopeial Convention  has opened a new expanded testing facility in the IKP Knowledge Park in Hyderabad, India. The new facility will allow voluntary testing and auditing program that helps dietary supplement manufacturers ensure and attest to the production of quality products for consumers.USP’s new facility expands its presence from 14,000 square feet to over 100,000 square feet; the number of employees will go from 70 to 90 in the coming year.

USP CEO Roger Williams said they are now poised to do more collaborative testing, verification testing, pharmacopeial education, customer support, and sourcing of written and physical standards for drugs, much of which we have been doing in concert with Indian manufacturers.

Latest stories

Related stories

Lilly, Insilico Sign $2.75B AI Drug Discovery Collaboration

Eli Lilly has expanded its engagement with Insilico Medicine,...

Daiichi Sankyo Enter AI Oncology Collaboration with Tempus

Daiichi Sankyo has formalised a strategic agreement with Tempus...

FDA Seeks Input on National Priority Voucher Pilot Program

The U.S. Food and Drug Administration has initiated a...

Merck Acquires Terns Pharmaceuticals in $6.7 Billion Deal

Merck, known as MSD outside the United States and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »